6273-58-1 Usage
Specific content
The chemical name of the compound
Specific content
The colloquial name or abbreviation for the compound
Specific content
The category and class to which the compound belongs
Specific content
The parent compound from which 4-MTA is derived
Specific content
The primary effects of the compound on the user
Specific content
The way the compound interacts with neurotransmitters in the brain
Specific content
The status of the compound as a recreational drug and its legal standing
Specific content
The potential negative health consequences of using the compound
Specific content
The association of the compound with fatal outcomes in some cases
Classification
Designer drug, amphetamine class
Derivative
Amphetamine
Effects
Stimulant and hallucinogenic
Mechanism of action
Serotonin and norepinephrine reuptake inhibitor
Recreational use
Unapproved, controlled substance
Adverse health effects
Hyperthermia, hyponatremia, serotonin syndrome
Fatalities
Linked to several deaths
Check Digit Verification of cas no
The CAS Registry Mumber 6273-58-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,2,7 and 3 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 6273-58:
(6*6)+(5*2)+(4*7)+(3*3)+(2*5)+(1*8)=101
101 % 10 = 1
So 6273-58-1 is a valid CAS Registry Number.
6273-58-1Relevant academic research and scientific papers
Reusable Nickel Nanoparticles-Catalyzed Reductive Amination for Selective Synthesis of Primary Amines
Murugesan, Kathiravan,Beller, Matthias,Jagadeesh, Rajenahally V.
supporting information, p. 5064 - 5068 (2019/03/19)
The preparation of nickel nanoparticles as efficient reductive amination catalysts by pyrolysis of in situ generated Ni-tartaric acid complex on silica is presented. The resulting stable and reusable Ni-nanocatalyst enables the synthesis of functionalized and structurally diverse primary benzylic, heterocyclic and aliphatic amines starting from inexpensive and readily available carbonyl compounds and ammonia in presence of molecular hydrogen. Applying this Ni-based amination protocol, -NH2 moiety can be introduced in structurally complex compounds, for example, steroid derivatives and pharmaceuticals.
